Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay

被引:1
作者
Bullen, WW [1 ]
Lathia, CD [1 ]
Abel, RB [1 ]
Hayes, RN [1 ]
机构
[1] Warner Lambert Co, Parke Davis Pharmaceut Res Div, Ann Arbor, MI 48105 USA
关键词
antiathersclerotic agent; CI-1011; LC/MS/MS; lipid regulator;
D O I
10.1016/S0731-7085(98)00034-X
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A liquid chromatographic/mass spectrometric (LC/MS/MS) method to quantitate CI-1011 in rat plasma has been validated and compared to an LC/UV assay. The analyte and internal standard were isolated from the plasma matrix by using liquid/liquid extraction with diethyl ether. The ether layer was evaporated to dryness and the residue reconstituted in acetonitrile-water (70:30, v/v). A 2.1 x 150 mm x 5 mu m Zorbax RX-C18 column with a mobile phase of acetonitrile-ammonium acetate (pH 8.0: 5 mM)-triethylamine (70.30:0.03, v/v/v) delivered at a flow rate of 0.2 mi min(-1) was used for chromatography. Analyte and internal standard ion chromatograms were obtained by operating the mass spectrometer in the negative ion multiple reaction monitoring mode to detect the presence of a precursor-product ion pair for both the analyte and the internal standard. Samples were introduced into the mass spectrometer using electrospray ionization. Retention times of CI-1011 and of the internal standard (IS), [C-13(6)]CI-1011, were approximately 4.2 min. No peaks interfering with the quantitation of CI-1011 were observed throughout the validation process. Mean recoveries of CI-1011 from rat plasma ranged from 98.2 to 105%. The recovery of the IS was 100%. Assay precision for CI-1011, based on the percent relative standard deviation of replicate quality controls, was less than or equal to 5.60% with an accuracy of +/- 8.80%. The lower limit of quantitation for CI-1011 was 0.500 ng ml(-1) for a 0.2-ml sample aliquot. CI-1011 is stable in rat plasma for 24 h at room temperature and for at least 34 days at -20 degrees C. This assay has been proven suitable for routine quantitation of CI-1011 in rat plasma at concentrations from 0.500 (100 pg on-column) to 500 ng ml(-1). The applicability of this method to determine CI-1011 concentrations in rat plasma is reported in this manuscript. CI-1011 concentrations, in plasma samples from cholesterol- and chow-fed rats administered single daily oral doses of CI-1011 in a CMC/Tween suspension, obtained using a validated LC/UV assay were compared to concentrations obtained using the reported LC/MS/MS assay over the concentration range 0.0806-12.3 mu g ml(-1). The concordance correlation coefficient determined for this comparison was 0.9977, suggesting that the CI-1011 concentrations obtained by the two assays are in excellent agreement. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1399 / 1413
页数:15
相关论文
共 5 条
[1]  
BEVINGTON PR, 1969, DATA REDUCTION ERROR, P105
[2]  
BOCAN TMA, 1995, 12 INT S DRUGS AFF L, P132
[3]  
Lathia C., 1997, Pharmaceutical Research (New York), V14, pS362
[4]   Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: An acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets [J].
Lee, HT ;
Sliskovic, DR ;
Picard, JA ;
Roth, BD ;
Wierenga, W ;
Hicks, JL ;
Bousley, RF ;
Hamelehle, KL ;
Homan, R ;
Speyer, C ;
Stanfield, RL ;
Krause, BR .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (26) :5031-5034
[5]   A CONCORDANCE CORRELATION-COEFFICIENT TO EVALUATE REPRODUCIBILITY [J].
LIN, LI .
BIOMETRICS, 1989, 45 (01) :255-268